Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avicanna Inc (TSX:AVCN)

0.2650 -0.0050 (-1.85%)
Streaming Delayed Price Updated: 3:09 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avicanna Inc

This Week In Cannabis: Carmelo's NY Launch, Federal Reform, Cancer Study, Avicanna's Growth, Tilray's Split, DeSantis Fallout, Slovenia's Big Move And More
Cannabis news this week: Congress revives cannabis reform, Slovenia leads Europe, Tyson takes charge and science backs cannabis for cancer care. 
Via Benzinga
Topics Cannabis
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Life Sciences Investor Forum Agenda Announced for March 13th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify
Colombia's cannabis decree allows dry flower sales, but ex-official claims it won't just protect small producers—most companies may qualify. 
Via Benzinga
Topics Cannabis
CBD's Toxicity Concerns: Could Europe Ban Cannabidiol In Cosmetics?
CBD could be deemed toxic for reproduction, which would then lead to its prohibition in cosmetic products across Europe. 
Via Benzinga
Avicanna Secures Nearly $2M In Private Placement Deal Amid US Patent Win For Cannabinoid Topical Formula
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that it has closed a non-brokered private placement offering of its 6,620,692 ‎‎units at $0.30 per unit for aggregate gross... 
Via Benzinga
Topics Intellectual Property
Avicanna Q2 Revenue Improves 85% YoY, Cannabis Company Touts Two Successful Trials On Drug Candidates
 
Via Benzinga
Topics Cannabis
Latest Cannabis Hires And Board Changes, Here's What You Need To Know
Cannabis ancillary company EnWave Corporation (TSX-V: ENW) (FSE: E4U) announced on Thursday that it had tapped Danna Dunnage as its new vice president of global sales and business development. Dunnage... 
Via Benzinga
Topics Cannabis
Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country
Cannabinoid-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that through its majority-owned subsidiary Santa Marta Golden Hemp the company... 
Via Benzinga
Topics Cannabis
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue
Cannabis-focused biopharmaceutical company Avicanna Inc. announced on Tuesday financial results for the first quarter of fiscal 2024.CEO Aras Azadian called it its "best quarter." In addition to being... 
Via Benzinga
CBD Helps With This Rare Blistering Skin Disorder, New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment
There is no cure for a rare blistering skin disorder called Epidermolysis Bullosa (EB). But, treatments to help alleviate and control the symptoms do exist. The growing body of research suggests... 
Via Benzinga
Topics Cannabis
Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY
Cannabinoids-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) reported on Tuesday year-end 2023 results and audited financial statements. The Canadian company... 
Via Benzinga
Topics Cannabis
CBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply Deal
Canadian cannabinoid-based biopharmaceutical firm Avicanna will supply two proprietary topical products to an unnamed multinational pharmaceutical firm in six European countries in 2024. The deal will... 
Via Benzinga
Canadian Cannabis Producer Reports Revenue Spike And Improved Margins In Q2, But What About Net Loss?
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced reported its interim second-quarter financial statements for the three months ending June 30, 2023. 
Via Benzinga
Topics Cannabis
CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Partners with Avicanna to Launch New Derma-Cosmetic Brand
Via CannabisNewsWire
Topics Cannabis
CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Partners with Avicanna to Launch New Derma-Cosmetic Brand
Via Investor Brand Network
Topics Cannabis
Avicanna Expands Medical Cannabis Brand RHO Phyto Into Caribbean Region With Export To Barbados
Avicanna Inc. (TSX:AVCN) (OTCQX: 
Via Benzinga
Topics Cannabis
Avicanna's CEO Touts Q3 As 'Most Successful Quarter To Date' As It Posts Record Results, Expands Into 12th International Market
CBD-focused biopharmaceutical company Avicanna Inc. (TSX:AVCN... 
Via Benzinga
Avicanna Colombia Gets Green Light To Ship Cannabis Flower & Biomass To Global Market
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE:0NN) announced Thursday that its Colombian subsidiary, Santa Marta Golden Hemp S.A.S., has met global conformity standards of Good... 
Via Benzinga
Topics Cannabis
Avicanna Completes Export Of CBD Isolate And Full Spectrum CBD From Colombia To Chile
CBD-focused biopharmaceutical company Avicanna Inc. (TSX:AVCN... 
Via Benzinga
Avicanna Ships Its Feminized Cannabis Seeds To Peru And Argentina
Avicanna Inc. (TSX:AVCN) (OTCQX: 
Via Benzinga
Topics Cannabis
Avicanna Files Patent For New Cannabinoid-Based Epilepsy Medication
Avicanna Inc., (TSX:AVCN) (OTCQX: 
Via Benzinga
Topics Intellectual Property
Avicanna Completes Registration And Commercial Export Of Pura Earth CBD Brand In Ecuador
Avicanna Inc. (TSX:AVCN) (OTCQX: 
Via Benzinga
Avicanna Reaches Brazil With Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts
Avicanna Inc. (TSX:AVCN) (OTCQX: 
Via Benzinga
Topics Cannabis
Avicanna Stock Down On Announcing $2.12M Raise Via Secured Term Loan Financing
Avicanna Inc. (TSX:AVCN) (OTCQX: 
Via Benzinga
Avicanna's Shares Jump On $3.2M Export Deal With Brazilian Pharmaceutical Company
Avicanna Inc. (TSX:AVCN) (OTCQX: 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.